The skin barrier and microbiome in infantile atopic dermatitis development: can skincare prevent onset?
International Immunology · 26.10.2024 · 36 (11) · 579-584
DOI: 10.1093/intimm/dxae038 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Immunology, online erschienen am 18.06.2024. Verfasst von Tomoka Ito und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, The University of Osaka, Graduate School of Medicine, Osaka 565-0871, Japan. Hauptthemen laut MEDLINE: Dermatitis, Atopic, Microbiota, Filaggrin Proteins, Skin. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 36 Literaturangaben. Gefördert von: JSPS KAKENHI, AMED-PRIME JP, AMED-CREST.
Abstract (Originalsprache)
Atopic dermatitis (AD), a prevalent Th2-dominant skin disease, involves complex genetic and environmental factors, including mutations in the Filaggrin gene and dysbiosis of skin microbiota characterized by an increased abundance of Staphylococcus aureus. Our recent findings emphasize the pivotal role of the skin barrier’s integrity and microbial composition in infantile AD and allergic diseases. Early skin dysbiosis predisposes infants to AD, suggesting targeted skincare practices as a preventive strategy. The effects of skincare interventions, particularly the application of moisturizers with the appropriate molar concentration of ceramides, cholesterol, and fatty acids, play a crucial role in restoring the skin barrier. Notably, our study revealed that appropriate skincare can reduce Streptococcus abundance while supporting Cutibacterium acnes presence, thus directly linking skincare practices to microbial modulation in neonatal skin. Despite the mixed outcomes of previous Randomized Controlled Trials on the efficacy of moisturizers in AD prevention, our research points to the potential of skincare intervention as a primary preventive method against AD by minimizing the impact of genetic and environmental factors. Furthermore, our research supports the notion that early aggressive management of eczema may reduce the incidence of food allergies, highlighting the necessity for multifaceted prevention strategies that address both the skin barrier and immune sensitization. By focusing on repairing the skin barrier and adjusting the skin’s microbiome from birth, we propose a novel perspective on preventing infantile AD and allergic diseases, opening new avenues for future studies, and practices in allergy prevention.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Dermatology, The University of Osaka, Graduate School of Medicine, Osaka 565-0871, Japan.
- Cutaneous Allergy and Host Defense, Immunology Frontier Research Center, The University of Osaka, Osaka 565-0871, Japan.
ORCID-Profile: Yuumi Nakamura
Förderung
- JSPS KAKENHI
- AMED-PRIME JP
- AMED-CREST
- AMED
- JST FOREST Program
- Joint Usage/Research Program of Medical Mycology Research Center, Chiba University
Zitieren
APA
Ito, T., & Nakamura, Y. (2024). The skin barrier and microbiome in infantile atopic dermatitis development: can skincare prevent onset?. International Immunology, 36(11), 579-584. https://doi.org/10.1093/intimm/dxae038
Vancouver
Ito T, Nakamura Y. The skin barrier and microbiome in infantile atopic dermatitis development: can skincare prevent onset?. International Immunology. 2024;36(11):579-584. doi:10.1093/intimm/dxae038
BibTeX
@article{Ito2024,
author = {Ito, Tomoka and Nakamura, Yuumi},
title = {The skin barrier and microbiome in infantile atopic dermatitis development: can skincare prevent onset?},
journal = {International Immunology},
year = {2024},
volume = {36},
number = {11},
pages = {579--584},
doi = {10.1093/intimm/dxae038}
}
EUVIMED